Page last updated: 2024-12-07

2-phenylsuccinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Phenylsuccinate is an organic compound that is the diester of succinic acid and phenol. It has been studied for its potential as a pharmaceutical agent. For example, 2-phenylsuccinate has been shown to have anti-inflammatory properties and may be useful in the treatment of inflammatory bowel disease. It has also been shown to have anti-tumor activity and is being investigated for its potential in the treatment of cancer. The synthesis of 2-phenylsuccinate involves the reaction of succinic acid with phenol in the presence of a catalyst. The compound is typically white solid that is soluble in organic solvents.'

Cross-References

ID SourceID
PubMed CID95459
CHEMBL ID76085
SCHEMBL ID146867
MeSH IDM0068553

Synonyms (58)

Synonym
CHEMBL76085
2-phenyl-succinic acid
2-phenyl-butanedioic acid
dl-phenylsuccinic acid
AD-232/25000151
635-51-8
nsc16635
nsc-16635
2-phenylsuccinate
nsc-11342
succinic acid, phenyl-
butanedioic acid, phenyl-
.alpha.-phenylsuccinic acid
phenylsuccinate
phenylsuccinic acid
nsc11342
2-phenylsuccinic acid
2-phenylbutanedioic acid
phenyl-succinic acid
phenylsuccinic acid, 98%
AC-10389
FT-0659274
FT-0652847
P0155
AKOS000120433
A800937
10424-29-0
A834412
nsc 11342
einecs 211-238-1
alpha-phenylsuccinic acid
butanedioic acid, 2-phenyl-
ai3-23845
nsc 16635
einecs 223-719-3
FT-0605277
FT-0605074
phenyl succinic acid
AB01141076-03
racemic phenylsuccinic acid
SCHEMBL146867
hydroxocobalaminhydrochloride
AKOS016842483
phenylsuccinicacid
W-104903
mfcd00004256
F2191-0207
(+/-)-phenylsuccinic acid
SY012920
AS-14727
EN300-20525
NCGC00334258-01
DTXSID60883518
CS-W015746
Z104478578
SY101159
mfcd02179706
SY060989
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID205501Binding affinity for Src SH2 domain in scintillation proximity binding assay (SPA) - inactive2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (30.56)18.7374
1990's8 (22.22)18.2507
2000's9 (25.00)29.6817
2010's8 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.85 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]